Developer docs
API playgroundTry for free, no card

Search company profiles

Sabal Therapeutics

Full company profile

uuid000egtw

Namestring
Sabal Therapeutics
Legal namestring
Sabal Therapeutics, LLC
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Sabal Therapeutics is a US-based pharmaceutical commercialization services firm founded in 2016 by Jeff Bryant and headquartered in Greenville, South Carolina, with additional offices in Watkinsville and Athens, Georgia. The company provides end-to-end commercialization support for pharmaceutical manufacturers seeking to enter or scale within the US market, organized around four service modules: Sales and Marketing Management, Product Distribution, Regulatory Compliance, and Accounting and Back Office. Its service offering spans sales strategy, product launch execution, inside and outside sales teams, contract sales deployment, multi-channel marketing, regulatory navigation, wholesaler distribution, order processing, warehousing, fulfillment, and back-office accounting.

The firm operates a multi-channel go-to-market model combining enterprise field sales (inside/outside sales teams, contract sales deployed nationwide, virtual direct sales) with channel partnerships through major pharmaceutical wholesalers and regional independent wholesalers focused on specialty pharmacies and physician networks. Sabal is licensed to ship product to all 50 states. Its customer segments are domestic pharmaceutical entrepreneurs and international pharmaceutical companies seeking US market access; publicly named partners include Athena Bioscience (cardiovascular portfolio, including Nexiclon XR launched March 2022), Metacel, and Palmetto Pharmaceuticals (the founder's prior 2015 acquisition). Revenue is generated via professional services fees on custom, quote-based engagements.

The business is founder-owned and private (Sabal Therapeutics, LLC, domiciled in Georgia) with no institutional investors, funding rounds, or M&A activity disclosed. The leadership team — including a 25+ year industry CEO, 30+ year CFO, and senior commercial and operations executives with backgrounds at Dura Pharmaceuticals, Elan, Eisai, Cornerstone Therapeutics, Praelia, and Mission Pharmacal — provides the differentiated expertise that anchors the company's value proposition for niche pharmaceutical assets that larger commercialization organizations typically bypass.

Short descriptiontext

Sabal Therapeutics is a US pharmaceutical commercialization services firm that provides sales, marketing, distribution, regulatory, and back-office services to domestic and international pharmaceutical companies seeking to enter or scale within the US market.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersWatkinsville, United States
HQ citystring
Watkinsville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical commercialization services, contract sales organization, pharmaceutical distribution services, regulatory affairs consulting, pharmaceutical sales management
Industry2 codes
PRIMARYHLAIAKAA
Pricing & Contracting Strategy
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Market Access and Pricing
SECONDARYCRAOAHAK
Pharmacy Benefit/Channel Services (PSAO, 340B Admin, Chargebacks/Rebates Ops)
NAICS code3 codes
  • Marketing Consulting Services541613
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
  • Wholesale Trade Agents and Brokers42512
SIC code3 codes
  • Services-Management Consulting Services8742
  • Services-Management Services8741
  • Services-Health Services8000
Product category
Pharmaceutical Commercialization Services
No data
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Pharmaceutical Commercialization Services
TypeProfessional Services
Description

Sabal provides comprehensive pharmaceutical commercialization services including sales management, product launch, regulatory compliance, product distribution, and accounting/back office support. Revenue is generated through service fees for these turn-key or individual specialty services offered to pharmaceutical companies seeking US market entry.

sabaltherapeutics.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Sabal Therapeutics provides end-to-end pharmaceutical commercialization services to pharmaceutical companies seeking to enter or expand in the U.S. market. Its offerings span four integrated modules: Sales & Marketing Management (sales strategy, inside/outside sales teams, product launch execution, multi-channel marketing), Product Distribution (major and regional wholesaler networks, order processing, warehousing, fulfillment across all 50 states), Regulatory Compliance (agency reporting, medical affairs, corporate compliance), and Accounting & Back Office (customized accounting, inventory management, and administrative support). Services are delivered individually or as turn-key market-entry solutions.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Sabal Therapeutics offers an integrated platform of pharmaceutical commercialization services consisting of four core modules: Sales & Marketing Management, Product Distribution, Regulatory Compliance, and Accounting & Back Office. The company provides end-to-end solutions for domestic entrepreneurs and international pharmaceutical companies seeking to enter or expand in the US pharmaceutical market, offering services from business analysis and product launch through distribution to all 50 states. Their model is designed to deliver custom-tailored strategies whether clients need individual specialty services or complete turn-key market entry solutions.

Product and service4 records
1Sales & Marketing Management
CategoryPharmaceutical Commercialization Services
Description

Comprehensive sales and marketing solution for pharmaceutical product commercialization, including sales management (business analysis, sales strategy, team performance, wholesale push-through), product launch collaboration with CROs, sales commercialization through inside/outside sales teams and contract sales teams deployed nationwide, virtual direct sales, and multi-channel product marketing (brand management, printed and digital deliverables, websites, direct mail, virtual lunch-and-learns, patient assistance programs). Designed for pharmaceutical companies seeking U.S. market execution.

2Product Distribution
CategoryPharmaceutical Distribution Services
Description

Multi-prong pharmaceutical distribution service covering major wholesale distribution to the big three pharmaceutical wholesalers, regional independent wholesalers focused on specialty pharmacies and physician networks, seamless order processing, inventory management, warehousing, and fulfillment. Licensed to ship product to all 50 U.S. states. Designed for pharmaceutical manufacturers needing nationwide distribution without building their own logistics network.

3Regulatory Compliance
CategoryPharmaceutical Regulatory Affairs
Description

Regulatory navigation services including agency reporting for safety requirements, medical affairs leadership (professional communications, safety reporting, clinical aspects of marketing and sales), and corporate compliance through standard operating procedures. Designed for pharmaceutical companies needing regulatory support for U.S. market commercialization.

4Accounting & Back Office
CategoryPharmaceutical Back Office Services
Description

Wide range of accounting and back office services custom-crafted for products and businesses, including inventory management, warehousing, and fulfillment operations. Designed for pharmaceutical companies seeking outsourced administrative and financial operations support for their commercialized products.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeGTM or Marketing PartnerAnnounced on2022-02-22
Description

Sabal Therapeutics announced a sales and marketing agreement to promote Athena Bioscience's cardiovascular product portfolio. Athena Bioscience subsequently launched Nexiclon XR (the only once-daily clonidine extended-release tablets for hypertension treatment) in March 2022. Sabal provides commercialization expertise including sales team management and product promotion for Athena's products.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Metacel (Metacelrx.com) is listed as a valued partner for whom Sabal provides pharmaceutical services and expertise. Metacel appears to be a specialty pharmaceutical company.

3Palmetto Pharmaceuticals
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Palmetto Pharmaceuticals is listed as a valued partner. Sabal's President and Founder Jeff Bryant purchased Palmetto Pharmaceuticals in 2015 before founding Sabal Therapeutics in 2016. Palmetto is a domestic pharmaceutical company with a focus on product development and commercialization.

sabaltherapeutics.com
Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Market position
Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Sabal Therapeutics

Pharmaceutical Commercialization Servicessabaltherapeutics.com

Sabal Therapeutics is a US pharmaceutical commercialization services firm that provides sales, marketing, distribution, regulatory, and back-office services to domestic and international pharmaceutical companies seeking to enter or scale within the US market.

What Sabal Therapeutics does

Sabal Therapeutics is a US-based pharmaceutical commercialization services firm founded in 2016 by Jeff Bryant and headquartered in Greenville, South Carolina, with additional offices in Watkinsville and Athens, Georgia. The company provides end-to-end commercialization support for pharmaceutical manufacturers seeking to enter or scale within the US market, organized around four service modules: Sales and Marketing Management, Product Distribution, Regulatory Compliance, and Accounting and Back Office. Its service offering spans sales strategy, product launch execution, inside and outside sales teams, contract sales deployment, multi-channel marketing, regulatory navigation, wholesaler distribution, order processing, warehousing, fulfillment, and back-office accounting.

The firm operates a multi-channel go-to-market model combining enterprise field sales (inside/outside sales teams, contract sales deployed nationwide, virtual direct sales) with channel partnerships through major pharmaceutical wholesalers and regional independent wholesalers focused on specialty pharmacies and physician networks. Sabal is licensed to ship product to all 50 states. Its customer segments are domestic pharmaceutical entrepreneurs and international pharmaceutical companies seeking US market access; publicly named partners include Athena Bioscience (cardiovascular portfolio, including Nexiclon XR launched March 2022), Metacel, and Palmetto Pharmaceuticals (the founder's prior 2015 acquisition). Revenue is generated via professional services fees on custom, quote-based engagements.

The business is founder-owned and private (Sabal Therapeutics, LLC, domiciled in Georgia) with no institutional investors, funding rounds, or M&A activity disclosed. The leadership team — including a 25+ year industry CEO, 30+ year CFO, and senior commercial and operations executives with backgrounds at Dura Pharmaceuticals, Elan, Eisai, Cornerstone Therapeutics, Praelia, and Mission Pharmacal — provides the differentiated expertise that anchors the company's value proposition for niche pharmaceutical assets that larger commercialization organizations typically bypass.

Sabal Therapeutics firmographics

Firmographics
Name
Sabal Therapeutics
Legal name
Sabal Therapeutics, LLC
Website
https://sabaltherapeutics.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
11–50 employees
Short description
Sabal Therapeutics is a US pharmaceutical commercialization services firm that provides sales, marketing, distribution, regulatory, and back-office services to domestic and international pharmaceutical companies seeking to enter or scale within the US market.
Ownership category
akta.pro rank

Sabal Therapeutics industry classification

Industry
Product category
Pharmaceutical Commercialization Services
NAICS
Marketing Consulting Services (541613), Drugs and Druggists' Sundries Merchant Wholesalers (424210), Wholesale Trade Agents and Brokers (42512)
SIC
Services-Management Consulting Services (8742), Services-Management Services (8741), Services-Health Services (8000)
akta.pro industry
PRIMARYHLAIAKAA
Pricing & Contracting Strategy
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Market Access and Pricing
SECONDARYCRAOAHAK
Pharmacy Benefit/Channel Services (PSAO, 340B Admin, Chargebacks/Rebates Ops)

Keywords

  • Pharmaceutical commercialization services
  • Contract sales organization
  • Pharmaceutical distribution services
  • Regulatory affairs consulting
  • Pharmaceutical sales management

Where Sabal Therapeutics is headquartered

Location

Headquarters

HQ city
Watkinsville
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Sabal Therapeutics business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain

Revenue model

  1. Pharmaceutical Commercialization Services: Sabal provides comprehensive pharmaceutical commercialization services including sales management, product launch, regulatory compliance, product distribution, and accounting/back office support. Revenue is generated through service fees for these turn-key or individual specialty services offered to pharmaceutical companies seeking US market entry.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels4 records

Sabal Therapeutics product offering

Product offering

Core offering

Sabal Therapeutics provides end-to-end pharmaceutical commercialization services to pharmaceutical companies seeking to enter or expand in the U.S. market. Its offerings span four integrated modules: Sales & Marketing Management (sales strategy, inside/outside sales teams, product launch execution, multi-channel marketing), Product Distribution (major and regional wholesaler networks, order processing, warehousing, fulfillment across all 50 states), Regulatory Compliance (agency reporting, medical affairs, corporate compliance), and Accounting & Back Office (customized accounting, inventory management, and administrative support). Services are delivered individually or as turn-key market-entry solutions.

Product overview

Sabal Therapeutics offers an integrated platform of pharmaceutical commercialization services consisting of four core modules: Sales & Marketing Management, Product Distribution, Regulatory Compliance, and Accounting & Back Office. The company provides end-to-end solutions for domestic entrepreneurs and international pharmaceutical companies seeking to enter or expand in the US pharmaceutical market, offering services from business analysis and product launch through distribution to all 50 states. Their model is designed to deliver custom-tailored strategies whether clients need individual specialty services or complete turn-key market entry solutions.

Differentiator

Problem solved

Functional benefit

Products and services

  • Sales & Marketing Management Comprehensive sales and marketing solution for pharmaceutical product commercialization, including sales management (business analysis, sales strategy, team performance, wholesale push-through), product launch collaboration with CROs, sales commercialization through inside/outside sales teams and contract sales teams deployed nationwide, virtual direct sales, and multi-channel product marketing (brand management, printed and digital deliverables, websites, direct mail, virtual lunch-and-learns, patient assistance programs). Designed for pharmaceutical companies seeking U.S. market execution.
  • Product Distribution Multi-prong pharmaceutical distribution service covering major wholesale distribution to the big three pharmaceutical wholesalers, regional independent wholesalers focused on specialty pharmacies and physician networks, seamless order processing, inventory management, warehousing, and fulfillment. Licensed to ship product to all 50 U.S. states. Designed for pharmaceutical manufacturers needing nationwide distribution without building their own logistics network.
  • Regulatory Compliance Regulatory navigation services including agency reporting for safety requirements, medical affairs leadership (professional communications, safety reporting, clinical aspects of marketing and sales), and corporate compliance through standard operating procedures. Designed for pharmaceutical companies needing regulatory support for U.S. market commercialization.
  • Accounting & Back Office Wide range of accounting and back office services custom-crafted for products and businesses, including inventory management, warehousing, and fulfillment operations. Designed for pharmaceutical companies seeking outsourced administrative and financial operations support for their commercialized products.

Companies that use Sabal Therapeutics

Customer profile

Named customers3 records

Segments2 records

Ideal customer profiles2 records

Sabal Therapeutics technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Sabal Therapeutics partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • Athena BiosciencecoreGTM or Marketing Partner · 22 February 2022Sabal Therapeutics announced a sales and marketing agreement to promote Athena Bioscience's cardiovascular product portfolio. Athena Bioscience subsequently launched Nexiclon XR (the only once-daily clonidine extended-release tablets for hypertension treatment) in March 2022. Sabal provides commercialization expertise including sales team management and product promotion for Athena's products.
  • MetacelminorGTM or Marketing PartnerMetacel (Metacelrx.com) is listed as a valued partner for whom Sabal provides pharmaceutical services and expertise. Metacel appears to be a specialty pharmaceutical company.
  • Palmetto PharmaceuticalscoreStrategic or Co-development PartnerPalmetto Pharmaceuticals is listed as a valued partner. Sabal's President and Founder Jeff Bryant purchased Palmetto Pharmaceuticals in 2015 before founding Sabal Therapeutics in 2016. Palmetto is a domestic pharmaceutical company with a focus on product development and commercialization.

Scale indicators6 records

Recent moves4 records

Expansion highlights4 records

Sabal Therapeutics competitors and assessment

Company assessment

Market position

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Sabal Therapeutics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Sabal Therapeutics leadership team

Management profile

Number of profiles

Profiles5 records

Sabal Therapeutics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Sabal Therapeutics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sabal Therapeutics

What does Sabal Therapeutics do?

Sabal Therapeutics provides end-to-end pharmaceutical commercialization services to pharmaceutical companies seeking to enter or expand in the U.S. market. Its offerings span four integrated modules: Sales & Marketing Management (sales strategy, inside/outside sales teams, product launch execution, multi-channel marketing), Product Distribution (major and regional wholesaler networks, order processing, warehousing, fulfillment across all 50 states), Regulatory Compliance (agency reporting, medical affairs, corporate compliance), and Accounting & Back Office (customized accounting, inventory management, and administrative support). Services are delivered individually or as turn-key market-entry solutions.

Is Sabal Therapeutics a public or private company?

Sabal Therapeutics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Sabal Therapeutics founded?

Sabal Therapeutics was founded in 2016. It employs 11 to 50 people.

Where is Sabal Therapeutics based?

Sabal Therapeutics is headquartered in Watkinsville, United States, in the North America region.

How does Sabal Therapeutics make money?

One revenue line is on record: pharmaceutical Commercialization Services.

Does Sabal Therapeutics have an API?

No public API is recorded for Sabal Therapeutics.

What industry is Sabal Therapeutics in?

Sabal Therapeutics's product category is Pharmaceutical Commercialization Services. Its primary akta.pro industry code is HLAIAKAA, Pricing & Contracting Strategy, with a secondary code of CRAOAHAK, Pharmacy Benefit/Channel Services (PSAO, 340B Admin, Chargebacks/Rebates Ops). Its NAICS code is 541613 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals